PTJ
BMY.RT

Paul Tudor Jones’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Paul Tudor Jones’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,264,818
Closed -$2.94M – 2987
2021
Q2 		$2.94M Hold
2,264,818
– – 0.06% 405
2021
Q1 		$2.15M Hold
2,264,818
– – 0.04% 495
2020
Q4 		$1.56M Buy
+2,264,818
New +$4.82M 0.04% 522
2020
Q3 		– Hold
0
– – – 294
2020
Q2 		– Hold
0
– – – 124
2020
Q1 		– Hold
0
– – – 40

Paul Tudor Jones's BMY.RT Position: Q3 2021 in Review

Paul Tudor Jones sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q3 2021, closing a stake of 2,264,818 shares — an estimated $2.94M sold.

Paul Tudor Jones first reported a position in BMY.RT in Q4 2020 and held it in 3 quarters. The position peaked at $2.94M in Q2 2021. 4 funds tracked by Wall St. Rank hold BMY.RT as of Q3 2021.

  • Paul Tudor Jones reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q3 2021 after selling out during the quarter.
  • Paul Tudor Jones sold 2,264,818 Bristol-Myers Squibb Company Contingent Value Rights shares in Q3 2021, an estimated $2.94M.
  • Paul Tudor Jones first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020 and held it in 3 quarters.
  • Paul Tudor Jones's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2.94M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q3 2021.

Based on Tudor Investment Corp's 13F filing for Q3 2021, filed 15 Nov 2021.